Abstract
Background
The increase in immigration in Barcelona between 2000 and 2008 forced a reorganization of the control of tuberculosis (TB). TB clinical units (TBCU) were created and community health workers (CHW) were gradually included.
Objective
To understand trends in the incidence of TB among immigrants, their main characteristics and treatment compliance during the period 1991–2013.
Design
We conducted a cross-sectional population-based study of cases detected among immigrants by the Tuberculosis Program in Barcelona, Spain. Sociodemographic, clinical characteristics and risk factors were described. The annual incidence was calculated for various periods and geographical areas of origin. In the linear trend analysis, a p-value of <0.05 was considered statistically significant.
Results
We detected 3,284 cases. Incidence decreased from 144.8/100,000 inhabitants in 1991 to 53.4/100,000 in 2013. Individuals born in Pakistan-India-Bangladesh had the highest average annual incidence (675/100,000). In all, 2,156 cases (65.7%) were male. 2,272 (69.2%) had pulmonary TB, of which 48.2% were smear-positive. 33% of the cases (1,093) lived in the inner city. Contact tracing (CT) coverage in smear-positive individuals rose from 56.8% in 1991–1999 to 81.4% in 2000–2013 (p<0.01); this value was less than 50% in people from Africa and Eastern European countries. The case fatality rate was 3.6% overall and 9.8% among those born in high-income countries (p<0.01). The highest rate of treatment default (12.8%) was observed among cases from the Maghreb. The rate of successful treatment increased from 69.9% in 1991–1999 to 87.5% in 2000–2013 (p<0.01).
Conclusion
The incidence of TB in immigrants is decreasing in Barcelona. Organizational actions, such as incorporating CHWs and TBCUs, have been decisive for the observed improvements.
Introduction
In many high-income countries (HIC), migration from countries with a high burden of tuberculosis (TB) has gradually increased, modifying the local epidemiology and making control difficult [1]. In some European cities disease rates have increased dramatically due to social problems and limitations in disease control activities [1]. In cities such as London, an increase of more than 50% was recorded between 1999 and 2009 [2, 3]. Despite the decreasing trend in incidence, the decrease in the number of TB cases among the native population in some countries has often been accompanied by an increase in foreign-born populations [4, 5]. In Spain, overall incidence, including that in immigrants, remains higher than in many industrialized countries [6, 7].
In January 2015, 4,718,864 foreigners were registered in Spain (10.1% of the total population), whereas this percentage was only 1.8% in 1999, representing an increase of almost four million people in 16 years [8]. These percentages are even higher in cities such as Barcelona and Madrid, where the immigrant population has come to represent 16.3% and 12.1% of the total population, respectively [9,10]. Although the rate of immigration has declined because of the economic crisis, this decline has been very modest in Barcelona, only 0.4% lower in 2014 than in 2013 (5,345 fewer people) [9].
This demographic change has had a major impact on the epidemiology of TB in Barcelona, resulting in a slower reduction in incidence [11]. However, it has been possible to maintain a high percentage of successful treatment (ST), with no major differences between natives and immigrants. However, contact tracing (CT) studies have been performed in 88% of native smear-positive patients, but in less than 50% of the immigrant population [12]. Since 2003, the Barcelona TB Control Programme (PPCTB), with the incorporation of community health workers (CHW), has taken strategic measures to support the public health nursing team (PHNT). This has improved action protocols for immigrant populations in terms of monitoring cases and their contacts in accordance with international guidelines [13].
The aim of this study was to describe trends in the TB incidence, its main characteristics and treatment compliance (TC), in a city where the impact of immigration from countries with high incidence has been very significant and concentrated over a short time span of a few years.
Methods
Design and study population
A population-based cross-sectional descriptive observational study was performed. Both globally and for specific groups, cases born outside Spain who began treatment between January 1991 and December 2013, who were registered by the PPCTB, and who were resident in Barcelona were studied.
Case definition
For the purposes of epidemiological surveillance and according to the European surveillance network’s criteria, TB case were defined as any patient who is prescribed TB treatment and complied with this until the expected time of completion, except if they died or presented serious side effects. Patients who restart TB treatment after more than one year are reincorporated into the case registry. Patients being treated for non-tuberculous mycobacteria are not considered cases [14].
Definition of immigrant
Person born in a foreign country.
Definition of geographical area of origin (Area of origin)
Cases were grouped into the following seven geographical areas based on their country of origin and their representation in the city: Latin America, India-Pakistan-Bangladesh, the Maghreb, high-income countries, Eastern Europe, the rest of Africa, and the rest of Asia.
Variables
We included the following socio-demographic variables (sex, age, area of origin, and district of residence), risk factors (homelessness, imprisonment, alcoholism, injecting drug use (IDU), HIV infection, and smoking), and clinical characteristics (type of TB, radiology, multidrug-resistance (MDR), resistance to rifampin and isoniazid, CT, directly observed treatment (DOT), and treatment outcome (TO): cured, treatment completed, died, lost to follow-up, transferred, other. The rate of successful treatment (ST) is defined as the sum of cured individuals plus those who completed treatment divided by the total number of patients, expressed as a percentage.
Statistical Analysis
Rates were calculated per 100,000 population. To calculate incidence rates, the denominator was the population of Barcelona born outside Spain, and also according to their geographic area of origin, as recorded in the city’s municipal census during the entire time series (1991–2013) [15].
We performed a descriptive analysis for the different variables by calculating proportions. Age as a quantitative variable was characterized by the median and interquartile range. Categorical variables were compared using the χ2 test. A p-value of <0.05 was considered statistically significant. The trend in the time series was calculated by fitting a line, and a p-value of <0.05 was considering statistically significant. All analyses were performed using the SPSS Statistical Package, version 13.0 (SPSS Inc, Chicago, IL, USA).
Results
Number of cases, distribution according to age, sex and sociodemographic characteristics
3,284 cases of TB were detected in immigrants residing in the city. Most came from Latin America (37.3%) and Pakistan, India and Bangladesh (26.6%). The average annual incidence was 105.9/100,000, decreasing from 144.8/100,000 in 1991 to 53.4/100,000 in 2013, representing an overall decline of 40.8%, and an average annual decline of 3.5% since 2000. This decline in incidence was observed in all clinical forms (Fig 1).
Fig 1. Trends in the incidence of pulmonary, mixed and extra-pulmonary tuberculosis in immigrants, Barcelona 1991–2013.
Table 1 shows the incidence of TB in the period from 1991 to 2013 according to geographical area of origin, and highlights the preponderance of men (65.7%; p <0.001), except among those from Latin America, where the percentage in each sex was similar. According to age group, the highest percentage was observed in individuals aged 25–44 years, with a similar distribution in men and women (40.7% and 41.1%, respectively). The Ciutat Vella district had a higher burden of disease (33.3%), especially among people from Pakistan, India and Bangladesh (Table 1).
Table 1. Main demographic characteristics of tuberculosis in immigrants, Barcelona, 1991–2013.
| Year: | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 |
| N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | |
| New cases of TB | 66 | 76 | 75 | 85 | 66 | 75 | 64 | 71 | 80 | 137 | 170 | 153 |
| Sex: | ||||||||||||
| Male | 48(72,7) | 65(85,5) | 56(74,7) | 60(70,6) | 51(77,3) | 42(56,0) | 37(57,8) | 47(66,2) | 50(62,5) | 87(63,5) | 127(74,7) | 106(69,3) |
| Age years: | ||||||||||||
| 0–14 | 0(0,0) | 0(0,0) | 1(1,3) | 0(0,0) | 0(0,0) | 0(0,0) | 0(0,0) | 1(1,3) | 0(0,0) | 3(2,2) | 1(1,3) | 3(2,2) |
| 15–24 | 7(10,7) | 17(22,6) | 17(22,6) | 9(10,6) | 7(10,6) | 11(14,7) | 15(23,5) | 16(22,5) | 12(15,1) | 34(25) | 37(21,8) | 35(22,9) |
| 25–44 | 45(69,3) | 51(68) | 41(56,6) | 60(70,6) | 47(71,2) | 52(69,3) | 40(62,5) | 41(57,7) | 58(72,5) | 81(59,6) | 105(61,7) | 97(63,4) |
| 45–64 | 8(12,3) | 5(6,8) | 12(16,0) | 13(15,3) | 12(18,2) | 6(8,0) | 8(12,5) | 7(9,9) | 9(11,3) | 14(10,3) | 17(10,0) | 16(10,5) |
| ≥65 | 5(7,7) | 2(2,6) | 4(5,3) | 3(3,5) | 0(0,0) | 6(8,0) | 1(1,6) | 6(8,4) | 1(1,3) | 4(2,9) | 10(5,9) | 2(1,4) |
| GAO: | ||||||||||||
| Latin America | 145 | 124 | 140 | 168 | 102 | 155 | 113 | 104 | 99 | 129 | 126 | 64 |
| Pak-Ind-Ban | 1565 | 3125 | 608 | 875 | 404 | 729 | 687 | 638 | 765 | 1621 | 948 | 546 |
| Maghreb | 158 | 128 | 394 | 258 | 220 | 114 | 120 | 161 | 170 | 165 | 296 | 170 |
| HIC | 38 | 68 | 47 | 52 | 87 | 66 | 33 | 37 | 20 | 57 | 22 | 35 |
| Eastern E | 190 | 174 | 0 | 461 | 296 | 277 | 0 | 318 | 175 | 339 | 124 | 139 |
| Rest of Africa | 770 | 491 | 394 | 309 | 264 | 346 | 980 | 390 | 491 | 493 | 625 | 136 |
| Rest of Asia | 164 | 152 | 197 | 337 | 145 | 158 | 118 | 162 | 193 | 247 | 132 | 91 |
| Municipal D: | ||||||||||||
| Ciutat Vella | 26(39,4) | 35(46,1) | 34(45,3) | 31(36,5) | 23(34,8) | 24(32,0) | 21(32,8) | 24(33,8) | 25(31,3) | 62(45,3) | 60(35,3) | 62(45,3) |
| Year: | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | Total |
| N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | |
| New cases of TB | 164 | 146 | 188 | 204 | 230 | 216 | 191 | 233 | 221 | 183 | 190 | 3284 |
| Sex: | ||||||||||||
| Male | 100(61,0) | 98(67,1) | 133(70,7) | 128(62,7) | 145(63,0) | 132(61,1) | 111(58,1) | 158(67,8) | 142(64,3) | 120(65,6) | 113(59,5) | 2156(65,7) |
| Age years: | ||||||||||||
| 0–14 | 4(2,4) | 4(2,7) | 7(3,7) | 2(1,0) | 1(0,4) | 3(1,4) | 3(1,6) | 0(0,0) | 2(0,9) | 0(0,0) | 3(1,6) | 38(1,2) |
| 15–24 | 32(19,5) | 26(17,8) | 32(17,0) | 35(17,2) | 44(19,2) | 56(26,0) | 32(16,8) | 46(19,8) | 51(23,1) | 27(14,7) | 28(14,7) | 626(19,1) |
| 25–44 | 105(64,0) | 99(67,8) | 126(67,0) | 128(62,8) | 151(65,7) | 126(58,3) | 130(68,1) | 147(63,1) | 128(57,9) | 119(65,0) | 123(64,7) | 2100(64,0) |
| 45–64 | 16(12,8) | 11(7,6) | 20(10,7) | 32(15,7) | 28(12,2) | 30(13,8) | 24(12,5) | 35(15,1) | 34(15,4) | 34(18,6) | 28(14,8) | 424(12,9) |
| ≥65 | 2(1,2) | 6(4,2) | 3(1,6) | 7(3,5) | 6(2,6) | 1(0,5) | 2(1,0) | 5(2,1) | 6(2,7) | 3(1,6) | 8(4,3) | 93(2,9) |
| GAO: | ||||||||||||
| Latin America | 61 | 48 | 56 | 56 | 72 | 57 | 48 | 50 | 41 | 32 | 28 | |
| Pak-Ind-Ban | 315 | 268 | 298 | 294 | 288 | 289 | 170 | 354 | 263 | 223 | 252 | |
| Maghreb | 152 | 75 | 101 | 93 | 109 | 44 | 73 | 104 | 114 | 76 | 83 | |
| HIC | 34 | 13 | 12 | 17 | 15 | 10 | 9 | 3 | 5 | 3 | 6 | |
| Eastern E | 48 | 123 | 82 | 71 | 78 | 72 | 96 | 62 | 97 | 44 | 67 | |
| Rest of Africa | 147 | 171 | 242 | 112 | 284 | 145 | 185 | 181 | 155 | 123 | 136 | |
| Rest of Asia | 77 | 41 | 61 | 78 | 58 | 77 | 37 | 53 | 28 | 48 | 53 | |
| Municipal D: | ||||||||||||
| Ciutat Vella | 65(39,6) | 48(32,9) | 55(29,3) | 62(30,4) | 71(30.9) | 61(28,2) | 41(21,5) | 84(36,1) | 59(26,7) | 55(30,1) | 65(34,2) | 1093(33,3) |
TB, tuberculosis; GAO, Geographic area of origin. For this variable, we show the annual incidence per 100.000 inhabitants; Pak-Ind-Ban, Pakistan-India-Bangladesh; HIC, High-income countries; Eastern E, Eastern Europe; Municipal D, Municipal district.
The highest average incidence was recorded among individuals from Pakistan, India, Bangladesh (675/100,000), followed by those from Africa (329/100,000), while that among individuals from high-income countries was only 30/100,000 (Fig 2).
Fig 2. Average annual incidence of tuberculosis in immigrants according to geographic area of origin.
Barcelona 1991–2013.
In relation to age, over 70% of cases were aged 20–49 years and the maximum incidence was observed among 20- to 29-year-olds. Notably, the average annual incidence in this age group decreased from 249/100,000 in the early years of the study to 77/100,000 in recent years (Fig 3).
Fig 3. Average annual incidence of tuberculosis in immigrants according to age group and period, Barcelona 1991–2013.
Risk factors and clinical features
According to area of origin, cases from Eastern European countries and high-income countries had a higher frequency of risk factors such as a higher proportion of homelessness, history of imprisonment, alcoholism and smoking (Table 2).
Table 2. Risk factors for immigrants with tuberculosis, Barcelona, 1991–2013.
| Geographic area | Latin America | Ind-Pak-Bang | Maghreb | HIC | Eastern E | Rest of Africa | Rest of Asia | Total |
|---|---|---|---|---|---|---|---|---|
| N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | |
| Cases of TB | 1224(37,3) | 874(26,6) | 360(11,0) | 173(5,3) | 198(6,0) | 199(6,1) | 256(7,8) | 3284(100) |
| Homelessness | 50(4,1) | 47(5,4) | 63(17,5) | 23(13,3) | 63(31,8) | 27(13,6) | 16(6,3) | 289(8,8) |
| Prison | 24(2,0) | 5(0,6) | 43(11,9) | 18(10,4) | 28(14,1) | 22(11,1) | 14(5,5) | 154(4,7) |
| Alcoholism | 152(12,4) | 61(7,0) | 71(19,7) | 48(27,7) | 58(29,3) | 37(18,6) | 32(12,5) | 459(14,0) |
| IDU | 32(2,6) | 5(0,6) | 19(5,3) | 46(26,6) | 39(19,7) | 15(7,5) | 12(4,7) | 168(5,1) |
| HIV | 145(11,8) | 5(0,6) | 25(6,9) | 60(34,7) | 31(15,7) | 50(25,1) | 12(4,7) | 328(10,0) |
| Smoking | 271(22,1) | 199(22,8) | 162(45,0) | 96(55,5) | 126(63,6) | 71(35,7) | 67(26,2) | 992(30,2) |
| Diabetes | 26(2,1) | 23(2,6) | 16(4,4) | 3(1,7) | 4(2,0) | 2(1,0) | 17(6,6) | 91(2,8) |
Ind-Pak-Bang, India-Pakistan-Bangladesh; HIC, High-income countries; Eastern E, Eastern Europe; IDU, Injecting drug use.
Regarding clinical characteristics, 58.1% of cases (n = 1909) had pulmonary TB, with the highest frequency observed among Eastern Europeans (77.3%). The most common type of extrapulmonary TB was lymphatic, with 638 cases (19.4%), followed by miliary TB, with 169 cases (5.1%), and osteoarticular TB, with 81 cases (2.5%). Notably, patients from the Indian subcontinent had a high percentage of extrapulmonary forms (49.8%), with lymphatic TB being the most common form in this group (337 cases, 38.6%). Latin Americans and Eastern Europeans had more cavitated and smear-positive forms People from Eastern Europe also showed more resistance to rifampicin (5.8%) and isoniazid (17.5%), and more MDR (4.5%) (Table 3).
Table 3. Clinical characteristics and indicators of tuberculosis control in immigrants, Barcelona, 1991–2013.
| Geographic area | Latin America | Ind-Pak-Bang | Maghreb | HIC | Eastern E | Rest of Africa | Rest of Asia | Total |
|---|---|---|---|---|---|---|---|---|
| Cases of TB | 1224(37,3) | 874(26,6) | 360(11,0) | 173(5,3) | 198(6,0) | 199(6,1) | 256(7,8) | 3284(100) |
| TB localization: | ||||||||
| Pulmonary | 798(65,2) | 319(36,5) | 240(66,7) | 125(72,3) | 153(77,3) | 113(56,8) | 161(62,9) | 1909(58,1) |
| Extrapulmonary | 294(24) | 435(49,8) | 87(24,2) | 29(16,8) | 29(14,6) | 61(30,7) | 68(26,6) | 1003(30,5) |
| Both | 129(10,5) | 119(13,6) | 31(8,6) | 18(10,4) | 15(7,6) | 25(12,6) | 26(10,2) | 363(11,1) |
| Radiology: | ||||||||
| Normal | 30(3,2) | 25(5,7) | 11(4,1) | 7(4,9) | 4(2,4) | 8(5,8) | 6(3,2) | 91(4,0) |
| A. cavited | 319(34,4) | 114(26,0) | 107(39,5) | 44(30,8) | 58(34,5) | 47(34,1) | 45(24,1) | 734(32,3) |
| A. non- cavited | 573(61,8) | 297(67,8) | 148(54,6) | 91(63,6) | 106(63,1) | 82(59,4) | 134(71,7) | 1431(63,0) |
| Smear-positive: | ||||||||
| Pulm TB smear BK + | 501(54,0) | 149(34,0) | 128(47,2) | 82(57,3) | 98(58,3) | 70(50,7) | 66(35,3) | 1094(48,2) |
| Drug resistance: | ||||||||
| Isoniazid | 79(8,5) | 46(8,7) | 14(6,3) | 6(5,0) | 27(17,5) | 14(10,4) | 20(12,0) | 206(9,2) |
| Rifampicin | 35(3,8) | 15(2,8) | 4(1,8) | 3(2,5) | 9(5,8) | 5(3,7) | 4(2,4) | 75(3,3) |
| MDR | 31(2,5) | 13(1,5) | 4(1,1) | 2(1,2) | 9(4,5) | 5(2,5) | 4(1,6) | 68(2,1) |
| DOT | 203(16,6) | 240(27,5) | 111(30,8) | 35(20,2) | 87(43,9) | 69(34,7) | 49(19,1) | 794(24,2) |
| CT (S.P. BK+): | ||||||||
| Done | 422(84,2) | 114(76,5) | 67(52,3) | 55(67,1) | 71(72,4) | 47(67,1) | 53(80,3) | 829(75,8) |
| Letality | 45(3,7) | 15(1,7) | 13(3,6) | 17(9,8) | 14(7,1) | 7(3,5) | 7(2,7) | 118(3,6) |
| ST | 1074(87,7) | 747(85,5) | 275(76,4) | 134(77,5) | 149(75,3) | 159(79,9) | 220(85,9) | 2758(84,0) |
Ind-Pak-Bang, India-Pakistán-Bangladesh; HIC, high-income countries; A. cavitated, abnormal cavitated; A. non-cavitated, abnormal non-cavitated; Pulm TB smear BK+, Pulmonar tuberculosis smear BK +; MDR, multidrug resistence; DOT, directly observed treatment; CT (S.P. BK+), contact tracing in smear-positive pulmonary patients; S.P., pulmonary smear-positive; bk+, smear-positive; ST, successful treatment.
Outcomes of treatment and directly observed treatment
The rate of ST for the entire study period was 84%, with a 17.6% improvement between 1991–1999 (69.9%) and 2000–2013 (87.5%) (p<0.01). There was 14.3% loss to follow-up during the first period, decreasing to 4.7% during the second period (p<0.01). The cure rate increased from 1.2% to 28% among individuals from all geographic areas of origin from 2000 to 2013. Table 3 shows the percentage of patients in DOT for each geographical area.
Overall lethality was 3.6% and showed a decreasing linear trend during the study period (p<0.01). Lethality was 6,4% for the period 1991–1999, decreasing to 2.9% during the period 2000–2013. Results for each geographical area are shown in Table 3.
Contact tracing (CT)
CT coverage increased from 56.8% in 1991–1999 to 81.4% in 2000–2013 (p<0.01). This percentage improved in all geographic areas during the second period, ranging from a 6.1% improvement in patients from Eastern Europe to a 30.6% improvement in those from Pakistan-India-Bangladesh. The lowest coverage was observed among Maghrebi patients and the highest among Latin Americans (Table 3).
Discussion
In this study, we found that the incidence of TB among immigrants in Barcelona decreased significantly during the study period, with an average annual decline of 3.5% since 2000. Following the incorporation of CHWs and TBCUs, there has been a significant increase in ST and CT coverage.
While incidence remains high, it should be noted that much of the immigrant population arrived less than ten years ago. The Ciutat Vella district in the city centre, which is the most socio-economically disadvantaged and has a high prevalence of immigrants [2, 16], has the highest incidence (mean 125.9/100,000 in the last 11 years) and is the area where most of the population from Pakistan, India and Bangladesh have settled. Therefore, it is recommendable to maintain and improve active case-finding mechanisms, DOT and CT in all areas of social interaction [17].
As observed in New York [18], London [19] and Paris [20], TB is more common among men. Men may have a higher prevalence of latent TB infection and greater exposure to conditions that favor development of the disease, such as alcoholism, smoking and precarious working conditions [21, 22]. Among Latin Americans however the prevalence was similar among men and women (48.9% and 51.1%, respectively), possibly because Latin American migration to Spain has mainly been led by women [23, 24], unlike for other communities such as Pakistan and Maghreb. In terms of age group, the most affected were those between 15 and 44 years, similar to reports for immigrants in New York and London [18, 19]. In this young adult working-age population, the effects of the migration process may ultimately provoke development of the disease as a result of endogenous reactivation or recent infections in the destination country. It is important to note that incidence has declined in this age group over the years, and is now more similar that in natives. This profile of high TB incidence in individuals of working age corresponds to that of a country or large city that has still not achieved good control over the disease. The trend is positive however, considering that there has been a decrease over time in the incidence of recent infections in this age group (Fig 3) [25, 26].
While the observed incidence decreased during the study period thanks to better control and monitoring by the PPCTB, the number of cases among immigrants increased from the year 2000 onward. This is due to the massive influx of immigrants from low-income countries with a high incidence of TB. However, since 2008 the economic crisis may have contributed to lower immigration and thus a reduction in the number of cases. The highest incidence recorded during the entire period was observed in young adults from Pakistan, India and Bangladesh. This phenomenon may be associated with the high burden of disease and low socio-economic status of people from these countries. The overall rate among immigrants in 2013 (53.4/100,000) was higher than that observed among immigrants throughout the country for the same year (31.8/100,000) [27, 28], and much higher that reported for the entire EU population (12.7/100,000) [29]. In our case, the active surveillance carried out in the PPCTB would have an effect, allowing practically all cases diagnosed in the city to be registered.
The joint analysis of sex, age and risk factors such as homelessness, history of imprisonment, alcoholism, HIV infection, IDU and smoking, shows that men, young adults, and those from Eastern Europe, the Maghreb and high-income countries have a higher frequency of risk factors and thus greater vulnerability and management complexity [30, 31].
Pulmonary TB is the most common form in immigrants [18, 19, 20], as observed in this study. However, we observed a high percentage of cases with extrapulmonary forms from Pakistan, India and Bangladesh (49.8%), whose clinical management is more difficult and who contribute less to disease transmission. However, this percentage is higher (74.7%) for the whole of Spain, probably because in some regions not all cases of extrapulmonary TB are reported [32]. Regarding radiology, we observed a high frequency of cavitary forms in people from the Maghreb, Latin America, Eastern Europe, and the rest of Africa. This may be related to greater diagnostic delay, even among individuals from countries who speak the same language, such as those from Latin America.
The percentage of MDR-TB cases observed in immigrants in this study was much lower than for other regions [33, 34]. The percentage of resistance in people from Eastern Europe was especially high for isoniazid, reflecting the high prevalence of resistance in this region. There was a downward trend in the percentage of patients with TB/HIV, which did not appear to affect the epidemiology of TB in the city. This may be due to better control of coinfection, the increasing effectiveness of antiretroviral drugs, and the low prevalence of HIV infection in countries like Pakistan, India and Bangladesh which together with Latin America, represent 63.9% of all TB in this time series.
The percentage of treated and cured cases was high throughout the study period (84%). This percentage was almost equal to that observed in natives, and meets the current WHO targets for the EU. We also observed a significant improvement of 17% for the period 2000–2013, which was not the case for EU as a whole [13], or for neighboring regions. The percentage of cases lost to follow-up decreased by 9.6% during the second period.
A high percentage of the contacts of smear positive cases were investigated and treated, and we observed a 43.9% increase in coverage between 1991–1999 and 2000–2013. However, more work is needed to improve the exhaustivity of CT and ST in patients from Africa and high-income countries, who more often live alone or form part of groups at risk of social exclusion.
We observed a clear decline in lethality during this period, with an annual average of 1.9%. While the percentage was higher for high-income and Eastern European countries, lethality did not exceed 10% for any geographic area. Since 1987, the PPCTB and its PHNTs have achieved good indicators in monitoring and tracking patients and the contacts of native patients [12]. From 2000 onward, coinciding with the massive influx of immigrants from endemic countries [35], and following international [36, 37, 38, 39, 40] and national [41] recommendations, the program has gradually incorporated CHWs that act in coordination with PHNTs, doctors, technicians and other social and health agents, especially those in the TBCUs. The actions of the CHWs have helped improve treatment adherence, the search and location of patients and their contacts, access to the health card for free care, and control of outbreaks in family, work and leisure contexts [42, 43]. However, there have been considerable difficulty in monitoring and tracking contacts from Eastern Europe and the Maghreb.
This is one of the few studies that have been conducted in the immigrant population in a major European city. It is a population-based epidemiological study with a long follow-up period, and is based on an extensive, very reliable and refined TB database that has systematically collected data on the country of origin of each patient since the beginning of the PPCTB in 1987. However, this study has various limitations, including difficulty in precisely determining the denominators of the immigrant populations. The city’s municipal register does not exhaustively record immigrants country of origin, and many irregular immigrants, fearing deportation, probably do not fully disclose their data to the public administration. Hence, these incidence rates should be considered an approximation to reality because the available register may not accurately reflect the number of residents born outside Spain. Also, the number of migrants at risk during the period 1991–1999 was lower than that for the period 2000–2013, which may have influenced the high rates reported in the first period. Another limitation of the study is related to risk factors, namely the fact that the program’s epidemiological survey does not collect data on BMI (body mass index), and therefore we could not provide results on this.
Conclusion
Immigration, especially massive immigration, is a challenge for TB programs, which must adapt to immigrants profiles according to their regions of origin. The adaptation of the PPCTB to these new challenges has allowed significant progress in the control and surveillance of the disease in immigrant groups over time. However, the results of our study demonstrate the need to continue encouraging monitoring and control activities, especially in immigrants from endemic countries. There is a need to maintain and improve active case-finding and tracking systems for both cases and contacts. In our case this was possible through coordinated intervention by PHNTs, case managers, CHWs, clinical units, and other health stakeholders, as well by promoting research and development in TB [35].
Ethics approval statement
Demographic and clinical data were obtained from an epidemiological questionnaire used by the PPCTB. TB is a notifiable disease and therefore it is mandatory to record patients’ names for interviewing. The data were processed and analyzed anonymously. The analysis was carried out retrospectively and the data involved were collected according to the protocol of the National Tuberculosis Program, approved by the Spanish Ministry of Health. Therefore, no ethical approval or informed consent of patients was required. All data were treated in strict confidence in accordance with the ethical principles of the 1964 Declaration of Helsinki, revised by the World Health Organization in Edinburgh, 2000 and the Spanish Organic Law 15/1999 on Data Protection. Declaration of Helsinki from the World Medical Association: http://www.isciii.es/htdocs/terapia/documentos/Declaración of Helsinki.pdf. Spanish Organic Law 15/1999 on Data Protection: http://noticias.juridicas.com/base_datos/admin/lo15-1999.html.
Acknowledgments
The authors express their thanks to the health and administrative staff of Barcelona Public Health Agency’s Epidemiology Service and Dr Gavin Lucas for critical reading and editing of the manuscript (www.thepapermill.eu). Special thanks to the doctors and microbiologists, public health teams and technicians, and the PHNTs and CHWs, who have worked in a coordinated manner and have formed part of PPCTB over the years. Without all their effort and dedication, the profile of TB in the city of Barcelona today would probably be very different. The Barcelona Tuberculosis Immigration Working Group collected the cases and reviewed the paper.
Barcelona Tuberculosis Immigration Working Group: Patricia García de Olalla, Cristina Rius, Martí Casals, Roser Clos, Eva Masdeu, Pere Simón, Mª José Santomà, Imma Badosa, Pilar Gorrindo, Anna de Andrés, Carmen Serrano, Tahir Rafí, Sayid Abdelkarim, Xiao Miao Lin, Ileana Burcea, Antonio Moreno, Llanos Roldán, Arancha Romero (Servicio de Epidemiología-Agència de Salut Pública de Barcelona). Núria Saborit, Israel Molina, José Angel Rodrigo and Teresa Tórtola (Servicios de Enfermedades Infecciosas, Medicina Preventiva y Microbiología del Hospital Universitario Vall d’Hebron. Barcelona), José Mª Miró, Anna Vilella, José A. Martínez and Julià González (Servicios de Enfermedades Infecciosas y Microbiología del Hospital Clínic Universitari-IDIBAPS. Barcelona), Francesca Sánchez, Glòria Sòria and Neus Jové (Servicios de Medicina Interna, Enfermedades Infecciosas y Microbiología del Hospital del Mar. Barcelona), Mª Antonia Sambeat, Virginia Pomar, Ma. Àngels Fontanet and Pere Coll (Servicio de Medicina Interna, Enfermedades Infecciosas y Microbiología. Hospital de Sant Pau. Barcelona), Mª Ángeles Jiménez, Celia Milà, Jordi Solsona, Adela Cantos and Mª Luiza de Souza-Galvão (Unitat de Tuberculosi Vall d'hebron-Drassanes. Barcelona), Israel Molina-Pinargote, Yoel-D González, Mariló Montes, Núria Forcada and Carmen Ruíz (Centro de Tratamiento Directamente Observado de la Tuberculosis. Servicios Clínicos. Barcelona).
Data Availability
Data are from the Tuberculosis Prevention and Control Program of the Public Health Agency of Barcelona. Authors may be contacted at jospina@aspb.cat or aorcau@aspb.cat. The data used in the study are data from mandatory notifiable diseases that according to the current Spanish legislation cannot be exposed to public use. These data are private data from individuals living with tuberculosis, HIV/AIDS or other communicable diseases. However, we are willing to provide the information taking into account the Spanish rules governing the protection of personal data of Law 15/1999, of December 13 (available at https://www.boe.es/boe/dias/1999/12/14/pdfs/A43088-43099.pdf), and the Royal Decree 994/1999, of June 11, that approving the regulations on security measures for automated files containing personal data. State Bulletin, June 25, 1999, no. 151, (available at https://www.boe.es/buscar/pdf/2008/BOE-A-2008-979-consolidado.pdf).
Funding Statement
The authors received no specific funding for this work.
References
- 1.Burki T. Tackling tuberculosis in London’s homeless population. Lancet 2010; 376: 2055–2056. Last accessed: 08/06/2016. Available: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2962282-9/fulltext 10.1016/S0140-6736(10)62282-9 [DOI] [PubMed] [Google Scholar]
- 2.Zumla A. The white plague returns to London—with a vengeance.Lancet 2011. 377:10–11. Last accessed on: 08/06/2016. Available: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)62176-9/fulltext#article_upsell 10.1016/S0140-6736(10)62176-9 [DOI] [PubMed] [Google Scholar]
- 3.Health Protection Agency (UK). Tuberculosis in the UK: Annual report on tuberculosis surveillance in the UK 2009. Last accessed on: 08/06/2016. Available: http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/Publications/InfectiousDiseases/Tuberculosis/0912TuberculosisintheUK/
- 4.Centers for Disease Control and Prevention. Trends in tuberculosis-United States, 2011. MMWR 2012; 61: 181–185. Last accessed on: 08/06/2016. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6111a2.htm 22437911 [Google Scholar]
- 5.European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2012. Stockholm, Sweden: ECDC, 2012. Last accessed on: 08/06/2016. Available: http://ecdc.europa.eu/en/publications/Publications/1203-Annual-TB-Report.pdf [Google Scholar]
- 6.World Health Organization. Global tuberculosis report, 2014.WHO/HTM/TB/2014.08. Geneva, Switzerland: WHO, 2014. Last accessed:08/06/2016. Available: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf [Google Scholar]
- 7.Gilbert RL, Antoine D, French CE, Abubakar I, Watson JM, Jones JA. The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Disease 2009; 13: 645–51. Last accessed: 08/06/2016. Available: http://www.ncbi.nlm.nih.gov/pubmed/19383200 [PubMed] [Google Scholar]
- 8.Instituto Nacional de Estadística: Notas de prensa 1, 2015 –Avance de la Estadística del Padrón Continuo. Datos provisionales. Last Accessed: 08/06/2016. Available: http://www.ine.es/prensa/np904.pdf
- 9.Ajuntament de Barcelona. Departament d’Estadística. 2015. Last Accessed: 08/06/2016. Available: http://www.bcn.cat/estadistica/castella/dades/inf/pobest/pobest15/part1/t11.htm
- 10.Ayuntamiento de Madrid. Madrid datos. Departamento de Estadística. Poblaciones extranjeras. Enero 2015. Last Accessed: 08/06/2016. Available: http://www.madrid.es/UnidadesDescentralizadas/UDCEstadistica/Nuevaweb/Publicaciones/Extranjeros/enero2015/C41115.pdf
- 11.Orcau A, Avella C, González A, García de Olalla P, Caylà JA: Tuberculosis in Barcelona. Public Health Agency of Barcelona. Report 2014. Last Accessed: 06/08/2016. Available: http://www.aspb.cat/quefem/docs/Tuberculosi_2014.pdf
- 12.Orcau A, García de Olalla P, Caylà JA: Tuberculosis in Barcelona. Public Health Agency of Barcelona. Report 2006. Last Accessed: 06/08/2016. Available: http://www.aspb.cat/quefem/docs/Tuberculosi_2006.pdf
- 13.Centers for Diseases control and Prevention: Guidelines for the investigation of contacts of persons with infectious tuberculosis.Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Rwcomm Report 2005, 54(RR-15):1–47. Last Accessed: 08/06/2016. Available: http://www.cdc.gov/mmwr/pdf/rr/rr5415.pdf [PubMed] [Google Scholar]
- 14.2008/426/EC: Comission Decission of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision N° 2119/98/EC of the European Parliament and of the Council. Last Accessed: 08/06/2016. Available: http://ec.europa.eu/health/ph_threats/com/docs/1589_2008_en.pdf
- 15.Consulta de los datos de empadronamiento en Barcelona. Ayuntamiento de Barcelona. Last Accessed: 08/06/2016. Available: http://www.mobileid.cat/es/servicios/consulta-de-los-datos-de-empadronamiento-en-barcelona
- 16.Hladun O, Grau A, Esteban E, Jansà JM. Results from Screening Inmigrants of Low-Income Countries: Data from a Public Primary Health Care. Journal of Travel Medicine, 20 de noviembre de 2013. Last Accessed: 08/06/2016. Available: http://onlinelibrary.wiley.com/doi/10.1111/jtm.12083/pdf [DOI] [PubMed] [Google Scholar]
- 17.Orcau A, García de Olalla P, Caylà JA: Tuberculosis en Barcelona. Agencia de Salud Pública de Barcelona. Reporte 2013. Last Accessed: 08/06/2016. Available: http://www.aspb.cat/quefem/docs/Tuberculosi_2013.pdf
- 18.New York City Department of Health and Mental Hygiene. Bureau of Tuberculosis Control Annual Summary, 2014. New York, NY. 2015. Last Accessed: 08/06/2016. Available: http://www1.nyc.gov/assets/doh/downloads/pdf/tb/tb2015.pdf
- 19.Public Health England. (December 2015) Tuberculosis in London: Annual review (2014 data), 2015. Public Health England: London. Last Accessed: 08/06/2016. Available: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/484927/Annual_review_of_tuberculosis_in_London_2014_data.pdf
- 20.Aït Belghiti F, Antoine D. L’épidémiologie de la tuberculose en France en 2013. Bull Epidémiol Hebd. 2015;(9–10):164–71. Last Accessed: 08/06/2016 Available in: http://www.invs.sante.fr/beh/2015/9-10/2015_9-10_3.html [Google Scholar]
- 21.Lozano Salazar JL, Plasencia Asorey C, Ramos Arias D, García Díaz R, Mahíquez Machado LO. Factores de riesgo socioeconómicos de la tuberculosis pulmonar en el municipio de Santiago de Cuba [artículo en línea] MEDISAN 2009;13. Last Accessed: 08/06/2016. Available: http://scielo.sld.cu/pdf/san/v13n4/san07109.pdf
- 22.Gegia M, Magee MJ, Kempker RR, Kalandadze I, Chakhaia T, Golub JE, et al. Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia. Bull World Health Organ. 2015. June 1;93(6):390–9. Last Accessed: 08/06/2016. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450709/ 10.2471/BLT.14.147439 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yepes del Castillo I: Scenarios of Latin American migration: transnational family life between Europe and Latin America. International Journal on Collective Identity Research. Vol. 2014/2 [paper 107] ISSN 1694-6495. Last Accessed: 08/06/2016. Available: http://dialnet.unirioja.es/descarga/articulo/4842074.pdf
- 24.Alcalde Campos R. Mujeres latinoamericanas inmigrantes jefas de hogares monoparentales en España Migraciones Internacionales [en linea] 2014, 7 (Enero-Junio). Last Accessed: 08/06/2016. Available: http://www.redalyc.org/articulo.oa?id=15129957006
- 25.Long R, Njoo H, Hershfield E. Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ. 1999;160:1185–990. Last Accessed: 08/06/2016. Available: http://www.cmaj.ca/content/160/8/1185.reprint [PMC free article] [PubMed] [Google Scholar]
- 26.Salihu HM, Naik E, O’Brien WF, Dagne G, Ratard R, Mason T. Tuberculosis in North Carolina: trends across two decades, 19801999. Emerg Infect Dis. 2001;7 3 Suppl:570–4. Last Accessed: 08/06/2016. Available: http://wwwnc.cdc.gov/eid/article/7/7/01-7739_article 10.3201/eid0707.010739 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Informe epidemiológico sobre la situación de la tuberculosis en España. Año 2013. Madrid, 2014. Last Accessed: 08/06/2016. Available: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/TB_Informe_2013_CNE_9febrero2015.pdf
- 28.Instituto Nacional de Estadística. Sección presa/Estadística del Padrón Continuo. INE 2015. Last Accessed: 08/06/2016. Available: http://www.ine.es/prensa/padron_tabla.htm
- 29.European Centre for Disease Prevention and Control. ECDC. TB situation in the EU/EEA 2013. Last Accessed: 08/06/2016. Available: http://ecdc.europa.eu/en/healthtopics/Tuberculosis/epidemiological_data/Pages/tuberculosis-situation-2013.aspx
- 30.Mitchell SL, Seoudi N, Hutchison DC, Drobniewski FA. Multidrug resistant tuberculosis: resistance rates to first and reserved antituberculosis drugs in the UK in 2008/9 and the role of rapid molecular test for drug resistance. Thorax 2010; published online Sept 29. 10.1136/thx.2010.148866 Last Accessed: 08/06/2016. Available: http://www.ncbi.nlm.nih.gov/pubmed/20880876 [DOI] [PubMed] [Google Scholar]
- 31.Hollo V, Amato-Gauci A, Kodmon C, Manissero D. Tuberculosis in the EU and EEA/EFTA countries. What is the latest data telling us? Euro surveill 2009;14: Pii = 19151. Last Accessed: 08/06/2016. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19151 [PubMed] [Google Scholar]
- 32.Cruz-Ferro E, Ursúa-Díaz M, Taboada-Rodríguez J. Epidemiology of tuberculosis in Galicia, Spain, 16 years after the launch of the Galician tuberculosis programme. International Journal of Lung Disease and TB, 11 October 2013. Last Accessed: 08/06/2016. Available: http://www.ingentaconnect.com/content/iuatld/ijtld/2014/00000018/00000002/art00003?crawler=true [DOI] [PubMed]
- 33.World Health Organization; Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010. Last Accessed: 08/06/2016. Available: http://apps.who.int/iris/bitstream/10665/44286/1/9789241599191_eng.pdf [Google Scholar]
- 34.World Health Orgatization. Anti-tuberculosis drug resistance in the world. Report no. 4. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008. Last Accessed: 08/06/2016. Available: http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf
- 35.Caylà JA, Orcau A. Control of tuberculosis in large cities in developed countries: an organizational problem. BMC Med. 2011. November 28;9:127 Last Accessed: 08/06/2016. Available: http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-9-127 10.1186/1741-7015-9-127 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.WHO. Global Tuberculosis Report 2015. 20thedition Last Accessed: 08/06/2016. Available: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1 [Google Scholar]
- 37.WHO. Guidelines on the Management of Latent Tuberculosis Infection The End TB Strategy. WHO/HTM/TB/2015.01. Last Accessed: 08/06/2016. Available: http://apps.who.int/iris/bitstream/10665/136471/1/9789241548908_eng.pdf?ua=1&ua=1 [Google Scholar]
- 38.CDC. Recommendations for Prevention and Control of Tuberculosis Among Foreign-Born Persons Report of the Working Group on Tuberculosis Among Foreign-Born Persons. September 18, 1998. / 47(RR16);1–26. Last Accessed: 08/06/2016. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/00054855.htm [PubMed] [Google Scholar]
- 39.Heldal E., Kuyvenhoven J. V., Wares F., Migliori G. B., Ditiu L., Fernandez de la Hoz K., et al. Diagnosis and treatment of tuberculosis in undocumented migrants in low- or intermediate-incidence countries. Int J Tuberc Lung Disease 2008; 12(8):878–888. Workshop Report. Last Accessed: 08/06/2016. Available: http://www.theunion.org/what-we-do/publications/official/body/RESS_Migration_Statement_IJTLD_August_2008-fin.pdf [PubMed] [Google Scholar]
- 40.van Hest NA, Aldridge RW, de Vries G, Sandgren A, Hauer B, Hayward A, et al. Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill. 2014;19(9):pii = 20728. Article DOI: 10.2807/1560-7917.ES2014.19.9.20728. Last Accessed: 08/06/2016. Available: http://www.ncbi.nlm.nih.gov/pubmed/24626210 [DOI] [PubMed] [Google Scholar]
- 41.UITB, SEPAR, GESIDA, SEIMC, SESP: Working group of the workshops of the Research Unit on Tuberculosis in Barcelona 2001 and 2002. Consensus document on imported tuberculosis. Barcelona. Med Clin 2003,121:549–562. Last Accessed: 08/06/2016. Available: http://www.elsevier.es/es-revista-medicina-clinica-2-articulo-prevencion-control-las-tuberculosis-importadas-13053401
- 42.Rodrigo T, Caylà JA, Galdós-Tangüis H, García de Olalla P, Brugal MT, Jansà JM: Proposing indicators for evaluation of tuberculosis control programes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis 2001, 5:432–440. Last Accessed: 08/06/2016. Available: http://www.ncbi.nlm.nih.gov/pubmed/11336274 [PubMed] [Google Scholar]
- 43.Ospina J, Orcau A, Millet JP, Sánchez F, Casals M, Caylà JA. Community health workers improve contact tracing among immigrants with tuberculosis in Barcelona. BMC Public Health 2012. 12:158 Last Accessed: 08/06/2016. Available: http://www.biomedcentral.com/1471-2458/12/158 10.1186/1471-2458-12-158 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data are from the Tuberculosis Prevention and Control Program of the Public Health Agency of Barcelona. Authors may be contacted at jospina@aspb.cat or aorcau@aspb.cat. The data used in the study are data from mandatory notifiable diseases that according to the current Spanish legislation cannot be exposed to public use. These data are private data from individuals living with tuberculosis, HIV/AIDS or other communicable diseases. However, we are willing to provide the information taking into account the Spanish rules governing the protection of personal data of Law 15/1999, of December 13 (available at https://www.boe.es/boe/dias/1999/12/14/pdfs/A43088-43099.pdf), and the Royal Decree 994/1999, of June 11, that approving the regulations on security measures for automated files containing personal data. State Bulletin, June 25, 1999, no. 151, (available at https://www.boe.es/buscar/pdf/2008/BOE-A-2008-979-consolidado.pdf).